T-cell depleted allogeneic HSCT for patients with relapsed, high-risk multiple myeloma permits long-lasting remissions in the absence of graft-versus-host disease and provides a platform for adoptive immunotherapeutic approaches Meeting Abstract


Authors: Koehne, G.; Devlin, S.; Landau, H.; Hassoun, H.; Lesokhin, A. M.; Lendvai, N.; Chung, D. J.; Bravo, C.; Giralt, S. A.
Abstract Title: T-cell depleted allogeneic HSCT for patients with relapsed, high-risk multiple myeloma permits long-lasting remissions in the absence of graft-versus-host disease and provides a platform for adoptive immunotherapeutic approaches
Meeting Title: 2014 BMT Tandem Meetings
Journal Title: Biology of Blood and Marrow Transplantation
Volume: 20
Issue: 2 Suppl. 1
Meeting Dates: 2014 Feb 26-Mar 2
Meeting Location: Grapevine, TX
ISSN: 1083-8791
Publisher: Elsevier Inc.  
Date Published: 2014-02-01
Start Page: S38
Language: English
ACCESSION: WOS:000331155400029
PROVIDER: wos
DOI: 10.1016/j.bbmt.2013.12.028
Notes: Oral Presentations Meeting Abstract: 24 -- BMT Tandem Meetings -- FEB 26-MAR 02, 2014 -- Grapevine, TX -- 1 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sergio Andres Giralt
    1066 Giralt
  2. Hani Hassoun
    335 Hassoun
  3. Guenther Koehne
    194 Koehne
  4. Heather Jolie Landau
    432 Landau
  5. Nikoletta Lendvai
    106 Lendvai
  6. Alexander Meyer Lesokhin
    374 Lesokhin
  7. David Chung
    249 Chung
  8. Sean McCarthy Devlin
    613 Devlin
  9. Christina Denise Bravo
    6 Bravo